Industry news

• NEWS FDA approves first gene therapy for Haemophilia B

  28 November 2022 Catherine Eckford / European Pharmaceutical Review

  Hemgenix, the first gene therapy for adults with Haemophilia B has been approved by the US Food and Drug Administration (FDA).

• Investments in the production of Russian substances for medicines may amount to 50 billion rubles

  28 November 2022 GxPnews

  Investments in the production of Russian substances for medicines for 10 plants (to be launched starting from 2023) may amount to 50 billion rubles, Deputy Minister of Industry and Trade Vasily Osmakov told the media. The statement was made at the interregional economics and energy industry forum in Volgograd.

• Innovation in pharma manufacturing quality systems

  24 November 2022 Dr Eduard Cayón / European Pharmaceutical Review

  Over the last 10 years, there has been an important change of focus in pharma towards biotech products and personalised therapies. These important new treatments are now emerging into manufacturing, with implications for the way that quality is monitored, managed and assured. Dr Eduard Cayón sets out some practical advice.

• Vladislav Shestakov: “The creation of a consortium for chemical raw materials production with state participation will contribute to the achievement of technological sovereignty”

  24 November 2022 GxPnews

  One of the effective tools for achieving technological sovereignty of the domestic pharmaceutical industry may be the creation of a consortium for the production of pharmaceutical, chemical and biotechnological raw materials to meet the needs of drug production. State participation is an important condition for the creation of such a structure. 

• A biotechnological substances production line has been opened at Medsyntez plant

  23 November 2022 GxPnews

  A new workshop for the production of biotechnological substances for women’s reproductive health has opened at Medsintez plant in Novouralsk, Sverdlovsk Region, according to the official website of the Plenipotentiary Representative of the President of the Russian Federation in the Ural Federal District.

• 4,000 jobs will be created at the new pharmaceutical complex in Solnechnogorsk

  23 November 2022 GxPnews

  The Moscow Architecture Department supported the architectural and urban planning solutions of the pharmaceutical production and logistics complex planned in Esipovo Industrial Park in the Solnechnogorsk municipal district. This is reported on the website of the Committee for Architecture and Urban Planning of the Moscow region.

• “Molecular sponge” for targeted drug delivery

  22 November 2022 Marchmont Innovation News

  Researchers at the Southern Federal University (SFedU) in Rostov-on-Don have developed novel nanodimensional containers for storage, target delivery and controllable dosing of drugs.

• New technology aimed at stopping degenerative cerebral dysfunctions

  22 November 2022 Marchmont Innovation News

  Researchers in St. Petersburg have come up with what they say is an “effectual” drug candidate to treat Alzheimer’s related degenerative cerebral dysfunctions. The St. Petersburg Institute of Bioregulation and Gerontology and the Pavlov Institute of Physiology are behind the research effort.

• The Ministry of Health has registered a domestic vaccine against smallpox

  21 November 2022 GxPnews

  Orthopoxvac, a domestically developed vaccine against smallpox, has been registered by the Ministry of Health of Russia. The information on the fact was published in the State Register of Medicines.

• Russia’s market of medical products has almost doubled in four years

  21 November 2022 GxPnews

  More than 80% of medicines from the Vital and Essential Drugs list ones are produced domestically, and more than 30% of medical devices are Russian-made, said Yevgeny Kamkin, Deputy Minister of Health of the Russian Federation.